Mangoceuticals, Inc. SEC filings MGRX

Mangoceuticals, Inc. has 240 filings in SEC EDGAR's recent list, going back to Aug 31, 2022. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (material agreement). The company's fiscal year ends on December 31.

Mangoceuticals, Inc. SEC filings
Form Description Filed Period
8-K Current report
Material agreement
Oct 9, 2026 Oct 8, 2026
424B5 Prospectus supplement Oct 9, 2026 —
4 Insider transaction Oct 6, 2026 Sep 30, 2025
4 Insider transaction Oct 6, 2026 Jul 28, 2026
4 Insider transaction Oct 6, 2026 Jul 28, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 6, 2026 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
Oct 1, 2026 Sep 30, 2026
8-K Current report
Agreement ended
Aug 21, 2026 Aug 19, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
425 Filing Aug 13, 2026 —
425 Filing Aug 6, 2026 —
425 Filing Aug 4, 2026 —
8-K Current report
Other events
Aug 4, 2026 Aug 4, 2026
425 Filing Jul 30, 2026 —
425 Filing Jul 30, 2026 —
8-K Current report
Material agreement, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Jul 30, 2026 Jul 28, 2026
S-8 Employee stock plan registration Jul 10, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Jul 2, 2026 Jun 29, 2026
10-Q Quarterly report May 19, 2026 Mar 31, 2026
NT 10-Q Filing May 15, 2026 Mar 31, 2026
10-K Annual report Apr 1, 2026 Dec 31, 2025
NT 10-K Filing Mar 31, 2026 Dec 31, 2025
4 Insider transaction Mar 20, 2026 Jun 5, 2025
4 Insider transaction Mar 20, 2026 Mar 16, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 17, 2026 Mar 16, 2026
8-K Current report
Regulation FD disclosure
Feb 23, 2026 Feb 23, 2026
8-K Current report
Regulation FD disclosure
Feb 19, 2026 Feb 19, 2026
8-K Current report
Listing notice
Feb 6, 2026 Feb 4, 2026
EFFECT Filing Jan 28, 2026 —
UPLOAD Letter from the SEC Jan 27, 2026 —
CORRESP Letter to the SEC Jan 26, 2026 —
S-1/A Amended registration statement Jan 23, 2026 —
S-1 Registration statement Jan 13, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Dec 19, 2025 Dec 18, 2025
424B5 Prospectus supplement Dec 19, 2025 —
8-K Current report
Material agreement, Other events
Dec 19, 2025 Dec 17, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
4 Insider transaction Dec 11, 2025 Dec 9, 2025
8-K Current report
Material agreement, New debt
Dec 10, 2025 Dec 4, 2025
4 Insider transaction Dec 9, 2025 Dec 5, 2025
144 Notice of proposed sale Dec 3, 2025 —
4 Insider transaction Nov 26, 2025 Nov 19, 2025
144 Notice of proposed sale Nov 19, 2025 —
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
10-Q/A Amended quarterly report Nov 14, 2025 Jun 30, 2025
8-K Current report
Other events
Nov 14, 2025 Nov 13, 2025
8-K Current report
Other events
Nov 13, 2025 Nov 13, 2025
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Officer or director change
Oct 29, 2025 Sep 15, 2025
4 Insider transaction Sep 30, 2025 Apr 10, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 30, 2025 —
4 Insider transaction Sep 12, 2025 Sep 9, 2025
4 Insider transaction Sep 12, 2025 Sep 9, 2025
4 Insider transaction Sep 12, 2025 Sep 9, 2025
4 Insider transaction Sep 12, 2025 Sep 9, 2025
8-K Current report
Officer or director change
Sep 12, 2025 Sep 9, 2025
8-K Current report
Material agreement, Unregistered share sale
Sep 2, 2025 Aug 26, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale
Aug 4, 2025 Jul 30, 2025
8-K Current report
Material agreement, Unregistered share sale
Jul 23, 2025 Jun 10, 2025
8-K Current report
Bylaw or fiscal year change
Jul 10, 2025 Jul 3, 2025
8-K Current report
Officer or director change
Jul 3, 2025 Jul 1, 2025
EFFECT Filing Jun 24, 2025 —
CORRESP Letter to the SEC Jun 20, 2025 —
UPLOAD Letter from the SEC Jun 20, 2025 —
EFFECT Filing Jun 18, 2025 —
CORRESP Letter to the SEC Jun 17, 2025 —
S-3 Shelf registration Jun 13, 2025 —
8-K Current report
Unregistered share sale
Jun 10, 2025 Jun 2, 2025
UPLOAD Letter from the SEC Jun 6, 2025 —
S-1 Registration statement May 30, 2025 —
8-K Current report
Material agreement, Unregistered share sale
May 30, 2025 May 15, 2025
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets
May 23, 2025 May 22, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
May 6, 2025 Apr 28, 2025
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Regulation FD disclosure
Apr 25, 2025 Apr 24, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Apr 17, 2025 Apr 11, 2025
8-K Current report
Officer or director change
Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
4 Insider transaction Apr 11, 2025 Apr 10, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 11, 2025 —
8-K Current report
Unregistered share sale
Apr 8, 2025 Mar 28, 2025
8-K Current report
Unregistered share sale
Apr 2, 2025 Mar 28, 2025
S-8 Employee stock plan registration Apr 1, 2025 —
8-K Current report
Unregistered share sale
Mar 28, 2025 Mar 25, 2025
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Mar 25, 2025 Mar 20, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
8-K Current report
Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Mar 19, 2025 Mar 17, 2025
8-K Current report
Material agreement, Unregistered share sale
Feb 19, 2025 Feb 14, 2025
DEF 14A Proxy statement Feb 18, 2025 Feb 18, 2025
8-K Current report
Material agreement, Unregistered share sale
Feb 12, 2025 Feb 7, 2025
8-K Current report
Other events
Feb 12, 2025 Feb 12, 2025
424B3 Prospectus Feb 10, 2025 —
424B3 Prospectus Feb 10, 2025 —
8-K Current report
Unregistered share sale, Officer or director change
Feb 7, 2025 Feb 3, 2025
PRE 14A Preliminary proxy statement Feb 6, 2025 Feb 6, 2025
8-K Current report
Material agreement, Unregistered share sale
Jan 31, 2025 Jan 27, 2025
SCHEDULE 13G Ownership over 5% (passive) Jan 22, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
Jan 21, 2025 Jan 15, 2025
3 Initial insider ownership Jan 21, 2025 Jan 14, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jan 15, 2025 Jan 9, 2025
8-K Current report
Material agreement, Unregistered share sale
Jan 8, 2025 Dec 31, 2024
8-K Current report
Material agreement, Unregistered share sale
Dec 26, 2024 Dec 18, 2024
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Other events
Dec 19, 2024 Dec 13, 2024
8-K Current report
Material agreement, Unregistered share sale
Dec 6, 2024 Dec 2, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
4 Insider transaction Nov 12, 2024 Nov 11, 2024
8-K Current report
Officer or director change
Nov 12, 2024 Nov 11, 2024
8-K Current report
Other events
Oct 31, 2024 Oct 30, 2024
8-K Current report
Unregistered share sale
Oct 25, 2024 Oct 18, 2024
8-K Current report
Material agreement, New debt, Other events
Oct 22, 2024 Oct 18, 2024
8-K Current report
Regulation FD disclosure
Oct 21, 2024 Oct 21, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
Oct 11, 2024 Oct 8, 2024
8-K Current report
Other events
Oct 3, 2024 Oct 3, 2024
8-K Current report
Unregistered share sale
Oct 2, 2024 Aug 15, 2024
8-K Current report
Other events
Oct 1, 2024 Oct 1, 2024
8-K Current report
Unregistered share sale
Sep 27, 2024 Sep 26, 2024
EFFECT Filing Sep 5, 2024 —
CORRESP Letter to the SEC Sep 3, 2024 —
AW Filing Aug 30, 2024 —
UPLOAD Letter from the SEC Aug 29, 2024 —
SC 13D/A Amended ownership over 5% (active) Aug 27, 2024 —
4 Insider transaction Aug 27, 2024 Aug 26, 2024
8-K Current report
Unregistered share sale, Officer or director change
Aug 23, 2024 Aug 22, 2024
S-1 Registration statement Aug 16, 2024 —
8-K Current report
Results of operations
Aug 15, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
POS AM Filing Jul 26, 2024 —
8-K Current report
Material agreement, Other events
Jul 11, 2024 Jul 9, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
Jul 2, 2024 Apr 26, 2024
4 Insider transaction Jun 27, 2024 Jun 25, 2024
144/A Filing Jun 24, 2024 —
144/A Filing Jun 20, 2024 —
144 Notice of proposed sale Jun 18, 2024 —
8-K Current report
Shareholder vote results
Jun 18, 2024 Jun 17, 2024
144 Notice of proposed sale Jun 10, 2024 —
8-K Current report
Unregistered share sale, Officer or director change
Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
SC 13D/A Amended ownership over 5% (active) Jun 5, 2024 —
4 Insider transaction Jun 5, 2024 Jun 3, 2024
ARS Annual report to shareholders May 16, 2024 Dec 31, 2023
DEF 14A Proxy statement May 16, 2024 May 16, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
S-8 Employee stock plan registration May 14, 2024 —
EFFECT Filing May 9, 2024 —
CORRESP Letter to the SEC May 7, 2024 —
S-1/A Amended registration statement May 6, 2024 —
PRE 14A Preliminary proxy statement May 6, 2024 May 6, 2024
8-K Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change, Other events
May 2, 2024 Apr 29, 2024
UPLOAD Letter from the SEC Apr 30, 2024 —
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Apr 25, 2024 Apr 19, 2024
S-1 Registration statement Apr 23, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Apr 11, 2024 Apr 5, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Officer or director change, Shareholder vote results
Mar 26, 2024 Mar 25, 2024
DEF 14A Proxy statement Mar 1, 2024 Mar 1, 2024
PRE 14A Preliminary proxy statement Feb 20, 2024 Feb 20, 2024
8-K Current report
Other events
Jan 25, 2024 Jan 24, 2024
8-K Current report
Other events
Jan 23, 2024 Jan 18, 2024
SC 13D/A Amended ownership over 5% (active) Jan 2, 2024 —
8-K Current report
Officer or director change
Jan 2, 2024 Dec 28, 2023
4 Insider transaction Dec 29, 2023 Dec 28, 2023
EFFECT Filing Dec 19, 2023 —
8-K Current report
Material agreement, Other events
Dec 19, 2023 Dec 15, 2023
POS AM Filing Dec 18, 2023 —
POS AM Filing Dec 15, 2023 —
EFFECT Filing Dec 14, 2023 —
S-1/A Amended registration statement Dec 12, 2023 —
CORRESP Letter to the SEC Dec 11, 2023 —
CORRESP Letter to the SEC Dec 11, 2023 —
CORRESP Letter to the SEC Dec 11, 2023 —
S-1 Registration statement Dec 11, 2023 —
CORRESP Letter to the SEC Dec 11, 2023 —
8-K Current report
Material agreement, Unregistered share sale
Dec 11, 2023 Dec 10, 2023
UPLOAD Letter from the SEC Nov 30, 2023 —
DRS Filing Nov 24, 2023 —
8-K Current report
Listing notice
Nov 7, 2023 Nov 3, 2023
8-K Current report
Listing notice
Nov 1, 2023 Oct 30, 2023
10-Q Quarterly report Oct 27, 2023 Sep 30, 2023
8-K Current report
Results of operations
Oct 19, 2023 Oct 19, 2023
4 Insider transaction Oct 4, 2023 Oct 3, 2023
8-K Current report
Officer or director change
Oct 4, 2023 Oct 3, 2023
8-K Current report
Material agreement
Sep 21, 2023 Sep 15, 2023
8-K Current report
Material agreement, Unregistered share sale
Sep 8, 2023 Sep 1, 2023
10-Q Quarterly report Jul 28, 2023 Jun 30, 2023
8-K Current report
Unregistered share sale
Jun 23, 2023 Jun 21, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
4 Insider transaction May 4, 2023 May 1, 2023
3 Initial insider ownership May 4, 2023 May 1, 2023
8-K Current report
Officer or director change, Regulation FD disclosure
May 4, 2023 May 1, 2023
SC 13D Ownership over 5% (active) May 3, 2023 —
4 Insider transaction May 2, 2023 Apr 4, 2023
S-8 Employee stock plan registration Apr 18, 2023 —
SEC STAFF LETTER Filing Mar 29, 2023 —
424B4 Prospectus Mar 22, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Misc Health & Allied Services, NEC (SIC 8090)
Listed as
MGRX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
TX
Headquarters
Dallas, TX
SEC filer status
, Emerging growth company
SEC CIK
1938046
Former names
MANGOCEUTICALS, INC. (until Oct 9, 2026)

Other Services-Misc Health & Allied Services, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.